6197 — Solasto Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedSmall CapSuper Stock

Annual income statement for Solasto, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	JAS	JAS	JAS	JAS	JAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	95,719	106,182	117,239	131,088	135,139
Cost of Revenue
Gross Profit	17,001	18,861	20,464	21,753	21,934
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	90,865	100,843	111,778	126,092	131,045
Operating Profit	4,854	5,339	5,461	4,996	4,094
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	6,965	5,354	5,641	5,418	4,141
Provision for Income Taxes
Net Income After Taxes	4,739	3,539	3,503	3,173	2,257
Net Income Before Extraordinary Items
Net Income	4,739	3,539	3,503	3,173	2,257
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	4,739	3,538	3,502	3,172	2,257
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	50	56.1	57.4	60.1	51.8
Dividends per Share